Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-10-12

Clinical Trial Update: A Study Investigating the Safety, Tolerability, and Efficacy of Elamipretide Topical Ophthalmic Solution for Treatment of Leber's Hereditary Optic Neuropathy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating safety, tolerability, and efficacy of elamipretide topical ophthalmic solution for Leber's Hereditary Optic Neuropathy has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • elamipretide topical ophthalmic solution (elamipretide)

Snippet

Sponsor: Stealth BioTherapeutics Inc. | Conditions: Leber's Hereditary Optic Neuropathy | Phase 2 | Status: COMPLETED | Results posted: 2021-10-12